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ABSTRACT
THE EFFECTS OF A PATHOGENIC MUTATION AND A BINDING PARTNER ON
THE ACTIVITY OF POLYCYSTIN ION CHANNELS
Haroon Chaudhry
Mutations within polycystin-1 (PC1) and transcient receptor potential polycystin
channel 2 (TRPP2) are the leading causes for development of the most common kidney
disease, Autosomal Dominant Polycystic Kidney Disease (ADPKD). Although
significant efforts have been made to investigate properties and characteristics of these
proteins over the last three decades, their roles in ADPKD and how mutations in these
proteins lead to cystogenesis is still largely unknown. In the current work, I have studied
a novel TRPP2 mutation found in a patient family diagnosed with ADPKD that removes
the stop codon and results in adding an additional twelve amino acids on the C-terminus
of the translated protein. My focus is to explore the characteristics of this mutation by
utilizing gain-of-function TRPP2 mutants to record channel activity. We found that the
pathogenic mutation significantly reduced TRPP2 expression and trafficking, leading to
reduced channel activity. Furthermore, this mutation also reduces the activity of the
heteromeric PC1/TRPP2 complex channel. My results gain insight into the pathogenesis
of ADPKD caused by a mutation on TRPP2. In the last part of this thesis, I have also
studied the role of a potential PC1 binding partner C1orf95, the human ortholog of the
STUM protein, in regulating the channel function of the PC1/TRPP2 complex.
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CHAPTER 1
!
INTRODUCTION
1.1 Calcium Signaling
Calcium is a vital second messenger that plays a role in many physiological functions,
and calcium signaling regulates many cell activities such as neurotransmission, cell
motility, metabolism, apoptosis, and many more crucial aspects (Clapham, 2007). Cell
signaling is activated by either release of calcium ions (Ca2+) that are intracellularly
stored, such as the endoplasmic reticulum, or they enter the cell via the plasma membrane
ion channels, for example the voltage-gated Ca2+ channels or other Ca2+ permeable
channels.

1.2 TRP Protein Family
Transient Receptor Potential (TRP) channels are a group of calcium permeable channels.
They are a diverse set of proteins whose primary function is to regulate the plasma
membrane permeability to a variety of ions. The first TRP channel gene was discovered
in Drosophila melanogaster in an analysis of a mutant fly whose photoreceptors failed to
retain a sustained response to maintained light stimuli (Montell and Rubin, 1989). TRP
proteins belong to a superfamily of cation-permeable channels, comprised of seven
subfamilies: TRPA (ankyrin), TRPC (canonical), TRPM (melastin), TRPV (vanilloid),
TRPN (NOMPC), TRPML (mucolipin) and TRPP (polycystin). Members of this
superfamily share the common features of six transmembrane segments, varying degrees
of sequence homology, and permeability to cations (Venkatachalam and Montell, 2007).
There has been a growing interest in TRP proteins since they are modulators of
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intracellular Ca2+ signaling, and there is evidence that TRP channels act as Ca2+ entry and
release channels (Gees, Colsoul, and Nilius, 2010).
1.3 ADPKD and Polycystins
Our focus has predominantly been to study the TRP channel polycystin (TRPP)
subfamily and its relatedness to Autosomal Dominant Polycystic Kidney Disease
(ADPKD). ADPKD is the most common inherited kidney disease, and is caused by
mutations in either PKD1 or PKD2 genes, encoding polycystin proteins polycystin-1
(PC1, also called PKD1) and TRPP2 (also called polycystin-2 or PC2, or PKD2). It
affects approximately 1:400 – 1:1000 individuals, and cause formation of fluid filled
cysts within the kidney leading to end-stage renal failure (Harris and Torres, 2009; Wu
and Somlo, 2000).
TRPP2 is expressed in a variety of tissues, such as epithelial cells, vascular smooth
muscle, cardiac myocytes, adrenal glands, ovaries, etc. (Ong, 2008). TRPP2 has 968
amino acids (109,561 Da), six transmembrane domains and intracellular N- and Ctermini. The carboxy-terminal of TRPP2 has been of particular interest due to its several
sequence elements required for proper function, a calcium-binding EF hand, a coiled-coil
domain, an ER retention motif, and an amino acid cluster. The EF hand has been
implicated in ion channel gating and the acidic cluster in protein trafficking. The coiledcoil domain is required for homomerization and heteromerization of TRPP2 subunits
(Semmo, Kottgen, Hofherr, 2014). TRPP2 has a large extracellular loop between the first
and second transmembrane domains. Similar to other TRP proteins, TRPP2 can form a
homomeric cation channel.
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PC1 is a large membrane protein containing 4,302 amino acids, comprising of eleven
transmembrane domains, a large extracellular N-terminus, a GPCR proteolytic site
(GPS), and a shorter cytoplasmic C-terminus (Tsiokas, 2009). Its last six transmembrane
domains share significant sequence and structural similarity with the six transmembrane
domain of TRPP2. Because of the well-recognized motifs on the N-terminus of PC1 are
involved in protein-protein, protein-saccharide, and protein-ligand interactions, PC1 is
thought to function as a cell surface receptor.
How the mutations in these two proteins lead to ADPKD remains rather unclear,
however, the two proteins likely participate in similar processes since their pathological
implications are similar. Indeed, evidence shows that PC1 and TRPP2 can form a
heteromeric receptor/ion channel complex in a 3:1 stoichiometric ratio with three TRPP2
subunits and one PKD1 subunit (Fig. 1) (Yu et al, 2009). A recently published cryo-EM
structure of this complex has confirmed this stoichiometry (Su et al, 2018). The assembly
is mediated by the C-terminal coil-coiled domains and the extracellular loops between the
first and second transmembrane domains of TRPP2 and the sixth and seventh of PC1 (Yu
et al., 2009; Salehi-Najafabadi et al, 2017). Mutations that disrupt the TRPP2 coiled-coil
domain trimer abolish the full length TRPP2 and PC1/TRPP2 complex and diminish the
surface expression of both proteins (Yu et al, 2009). The PC1/TRPP2 complex was also
found to express in the primary cilia of renal epithelial cells, where they may play
essential roles in controlling renal tubular differentiation. Hence, it is important to
evaluate the molecular mechanisms underlying the structure and function of the assembly
in order to understand its physiological relevance.
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Figure 1. The PC1/TRPP2 receptor-ion channel complex. The PC1 and TRPP2
proteins share sequence homology over the transmembrane segments and contain a large
loop separating the first two transmembrane domains. TRPP2 can form an ion channel
complex with PC1 via the intracellular C-terminus at the coiled-coil domain in a three
TRPP2: one PC1 stoichiometric ratio. PC1 is cleaved after being synthesized at the Nterminal GPS site, which generates the N-terminal fragment (NTF) and the 11
transmembrane C-terminal fragment (CTF). The GPS cleavage is essential for the function
of PC1.

!
1.4 PC1 and TRPP2 mutations
ADPKD patients carry germ-line mutations in one allele of either PC1 or TRPP2.
Mutations in PC1 are responsible for approximately 80 percent of cases of ADPKD, and
TRPP2 mutations account for approximately 15 percent (Bergmann et al, 2018), while
the remaining 5-10 percent are due to rare mutations within other loci (Gall, Torres, and
Harris, 2018). However, an additional factor besides the germ-line mutation may be
required for the phenotype of ADPKD. A somatic inactivation of the remaining allele
associated with this disease, which suggest a two-hit model for this type leads to
cystogenesis in ADPKD patients (Pei et al, 1999). From the ADPKD mutation database,
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there are 2,303 germ-line mutations of PC1, of which 1,273 are pathogenic. For TRPP2,
there are 278 germ-line mutations, of which 202 are pathogenic. These mutations range
from frame-shift, missense, substitution, nonsense mutations, etc. Although, many are
truncation or deletion mutations.
Our collaborator at the University of Toronto, Dr. York Pei, treated a patient family which
has been diagnosed with ADPKD, and found a novel single point mutation at the stop
codon of the TRPP2 gene. The mutation adds an additional twelve amino acids
(NIHTKSYTQRLF) on the C-terminal fragment of the translated protein. We refer to this
unique mutation as TRPP2-12aa (for twelve amino acids). Studying this pathogenic
mutation may shed light on how this mutation affects the channel complex and more
insight to understanding the molecular mechanisms underlying ADPKD.
1.5 STUM proteins
Animal locomotion depends on proprioceptive feedback (Desai et al, 2014), and is
generated by mechanosensory neurons. In Drosophila, the mechanosesnation is mediated
by multi-dendritic neurons, however, it is not clear how those neurons can be tuned to a
joint angle modality. Performance of a genetic screening for impaired walking in
Drosophila mapped to a gene, CG30263, which encodes a protein with 1870 or 1959
amino acids (Desai et al, 2014). This gene is named STUM, in short for stumble, due to a
walking impairment. The human ortholog of the STUM gene is a member of the SPEC3
family, named C1orf95 (Chromosome 1 open reading frame 95). Mutations within this
gene underlie un-coordination (Desai et al, 2014). The STUM protein is highly conserved
among vertebrates and is predicted to contain two transmembrane domains.
Propioceptive defects in adult flies have been attributed to malfunction of type-1
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mechanoreceptor (ciliated) neurons (Avidor-Reiss et al, 2004). Electrophysiological
recordings of mechanical responses from this type of neuron of the anterior notopleural
bristle were taken to test whether the same defects underlie the STUM mutant. STUM
expression within in the legs was localized to three neurons, at the femur-tibia joint, the
tibia-tarsus joint, and the second tarsal segment. The dendrites of these neurons
terminated at the former joints. These joint angles induced dendritic stretching and
elicited an elevation of cellular calcium levels, these are not seen in STUM mutants
(Desai et al, 2014).

We find the human ortholog of STUM (C1orf95) of particular interest, because this
protein is found decreased in urinary exosomes from ADPKD patients. Biogenesis of
exosomes involves the inward budding of endosomes to form multi-vesicular bodies
(MVB). MVB coordinates transport of cargo, this process is facilitated by different
mechanisms that involves ESCRT machinery or lipid rafts. C1orf95 exists in two
isoforms within the human kidney, Exon 3- and Exon 3+. The third exon is a microexon
of nine base pairs that is differentially spliced. C1orf95 is expressed and co-localized in
the plasma membrane, MVB, and cilia, and co undergo palmitoylation. Both isoforms
can elicit current in electrophysiological settings. C1orf95 is involved with the generation
of giant vesicles up to two-micron size, and it is a subunit of stretch gated Ca2+ channel
complex involved in proprioception in Drosophila. Our collaborator, Dr. Christopher
Ward at University of Kansas Medical Center found that C1orf95 has interaction with
PC1/TRPP2 complex in kidney exosomes. Thus, it is reasonable to test if C1orf95 may
be associated with the PC1/TRPP2 complex channel activity.
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CHAPTER 2
MATERIALS AND METHODS
2.1 Polymerase Chain Reaction
Template: HA-tagged TRPP2-F604P and TRPP2_L677A_N681A gain-of-function
mutants (previously generated by Yong Yu’s laboratory) were inserted into pGEMHE2Yu vector. Q5 Forward and Reverse primers for adding 12aa to the C-terminus of
TRPP2 were used. Q5 Polymerase (Invitrogen) was used. Denaturation 98°C (10 sec).
Annealing 60°C (3 min). Extension 72°C (30 sec).
2.2 Gel Electrophoresis
PCR product was analyzed on 1% agarose gel at 130V for 20 minutes. Correct products
were treated with KLD reaction (NEB). Ligation product was added to DH5α competent
cell—fast transformation and plated onto a carbenicillin antibiotic plate. Incubation
overnight at 37°C.
2.3 Plasmid Preparation
Colonies grown on antibiotic plate were picked and cultures grown for 18-20 hours at
37°C. Miniprep performed on bacterial cultures (Epoch Life Sciences). Test cut
performed on purified plasmid with restriction enzyme HindIII (NEB) and Cutsmart
Buffer (NEB) incubation at 37°C for 1 hour, cut site at 5kb and 0.8kb. Sample sent for
sequencing (Eurofins Genomics) and blasted (NCBI blast). V5 tagged C1orf95_E3+ and
E3- plasmids (provided by Chris Ward at KUMC), propagated on kanamycin bacterial
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plate and purified during miniprep (Epoch).
2.4 RNA Transcription
DNA purification: linearize DNA using Buffer CS (NEB) and restriction enzyme Mlu1HF (NEB), incubation overnight at 37°C. In vitro RNA transcription using T7 RNA
Polymerase (incubation at 37°C for 3 hours). RNA was analyzed on RNA gel and
concentration measured using a spectrophotometer. BsaI restriction enzyme (NEB) used
to linearize the 3’ end and T7 polymerase to run off the mRNA for C1orf95+E3 and
C1orf95-E3.
2.5 Electrophysiology
Micro-injection of 1µl of RNA into needle (1.5µg/µl for HA-TRPP2-F604P and 1.8µg/µl
and 5.4µg/µl for HA-TRPP2-F604P_12aa), (1.0 µg/µl for PC2_AA/TM11 and 1.0 µg/µl
PC2_AA_12aa/TM11) injected into defolliculated Xenopus laevis oocytes (~50 ng of
RNA per oocyte). Oocytes were incubated at 18°C for 2-3 days before measuring current
using the two-electrode voltage clamp (TEVC) system. Currents were recorded at room
temperature in divalent ion-free bath solution [100mM NaCl 99%, 2mM HEPES (pH 7.5
by NaOH/HCl)] and Ca2+ containing bath solutions [2mM CaCl2, 100mM NaCl, 2mM
HEPES (pH 7.5 by NaOH/HCl)] and [70mM CaCl2, 2mM HEPES (pH 7.5 by NMDG)].
A standard TEVC protocol was used holding oocytes at 0 mV and measuring the currentvoltage (I-V) relationship by applying steps from -80mV to +60mV. Micro-injection of
1µl RNA of C1orf95+/-E3 (1µg/µl) into Xenopus oocytes (~50 ng per oocyte). Same
protocol as GOF TRPP2 mutations used for the human stum ortholog.
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2.6 Cell Lysis
After 2-3 days post-injection and recording via TEVC system, oocytes were collected (8
oocytes per group) and homogenized in lysis solution [10µl/oocyte, 1X PBS, 10uM
EDTA, 1% DDM, 10% glycerol, 1:50 protease inhibitor (Sigma Aldrich)]. Homogenized
samples sonicated twice on ice [70% amplitude for 2 minutes (1 pulse/sec)]. Sonicated
samples were incubated at 4°C for 1 hour and gently vortexed in 15 minute intervals.
Lysates were pelleted by centrifugation at 13,000 rpm at 4°C for 30 minutes. The
supernatants were collected on ice and treated with 3X SDS. SDS treated samples were
incubated in 37°C for 30 minutes. Same protocol used for human stum ortholog.
2.7 SDS-PAGE and Western Blot
SDS treated samples were loaded onto Bolt 4-12% Bis-Tris Plus gels (Invitrogen by
Thermo Fisher Scientific) and transferred onto PVDF (Bio-Rad). After transfer, the
membrane was blotted with mouse monoclonal anti-P2 (YCE2) (Santa Cruz
Biotechnology) or anti-HA (Biolegend) primary antibodies for 1 hour at room
temperature or overnight at 4°C. The membrane was blotted with HRP-conjugated goatanti-mouse secondary antibody for 1 hour at room temperature. Images were visualized
using Odyssey CLx (LICOR) and Image Studio Ver 5.2. 10% Bis-Tris Plus (Invitrogen)
gels used for c1orf95 samples. Anti-5183 (P1), anti-P2 (YCE2), and anti-V5 primary
antibodies used. GaM 680 and GaR 800 secondary antibodies used. Film analyzed using
LICOR system.
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2.8 Surface Biotinylation
Approximately 30 oocytes were collected per group and washed with cold 1X OR2
solution, then incubated with Sulfo-NHS-SS-Biotin (Pierce) in 1X OR2 solution
(6mg/10ml) for 30 minutes at 4°C with gentle agitation. The reaction was quenched with
500 ul of Quenching Solution (Pierce Surface Protein Isolation Kit) for 5 minutes and
then washed off Tris-buffered saline (TBS), three times. The oocytes were lysed
according to oocyte lysis protocol (see above), and the collected supernatant was partially
saved as the whole cell lysate sample, and the remainder was combined with NeutrAvidin
Agarose (Pierce Kit; 80 ul/sample washed with PBS-T, three times) in the provided
column. The bottom plug and top cap were secured and the columns were incubated
overnight at 4°C with rotary mixing. After centrifuging and discarding the supernatant,
the NeutrAvidin Agarose were washed with Wash Buffer [provided or made (1X PBS,
1% DDM, 0.1% Tween-20, 1/100 protease inhibitor, 1M NaCl, and 1% TritonX-100)],
three times. The protein was eluted by adding 75 ul of 1.5X SDS with 50 mM DTT to the
agarose and incubated in 37°C for 30 minutes before centrifuging to collect the
supernatant.
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CHAPTER 3
THE EFFECT OF 12AA MUTATION ON POLYCYSTIN CHANNEL ACTIVITY
3.1 The extra C-terminal 12 aa reduces the activity of a GOF TRPP2 (TRPP2F604P) channel
Due to the lack of a known activation mechanism of the TRPP2 homomeric channel and
the PC1/TRPP2 heteromeric channel, it has been difficult to study the function and
regulation of these channels and their roles in ADPKD. To facilitate the study of these
channels, our laboratory have generated a series of gain-of-function (GOF) mutants of
TRPP2. One of these mutants, TRPP2-F604P, has been used extensively in studying
TRPP2 channel function (Pavel et al, 2016). TRPP2-F604P exhibits robust current when
expressed in Xenopus oocytes and recorded using the two-electrode voltage clamp
method following cRNA injection (Pavel et al, 2016). Recently, we have solved the cryoEM structure of the TRPP2-F604P, which shows that the substitution of phenylalanine
with proline disrupts the S4-S5 linker and the hydrophobic interactions between S5-S6,
causing a conformational change of the S6 helix, opening the lower gate of the channel
(Zhen et al, 2018 ). Similar channel gating mechanisms have been found before in other
TRP channels (Cao et al, 2013; Schmeige et al, 2017, Zhen et al, 2018). The GOF TRPP2
provides a powerful tool for TRPP2 functional studies. In the current work, we have
applied this GOF mutant to study the effect of the novel 12 amino acid mutation on
TRPP2 channel function. By adding these 12 amino acids onto the C-terminus of TRPP2F604P channel, we generated a new mutation named TRPP2-F604P-12aa (Fig. 2).
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Figure 2. A novel pathogenic mutation of TRPP2. The mutation happens at the stop codon
and leads to the additional twelve amino acids found at the TRPP2 C-terminus.

We first checked whether the 12 aa mutation affects the expression of TRPP2 in oocytes.
To do that, we used a western blot method to compare the expression level of TRPP2F604P and that of the TRPP2-F604P-12aa. When we injected the same RNA
concentration (1.8µg/µl) for TRPP2-F604P and TRPP2-F604P-12aa into oocytes, we
found that 12aa mutation gave much less expression than TRPP2-F604P (Fig 3A). By
analyzing the band intensity with Image J, we figured out that the overall expression of
the TRPP2-F604P was approximately 3-fold of that of the TRPP2-F604P-12aa.
Consistently, when we increase the RNA concentration of TRPP2-F604P-12aa to 5.4
µg/µl, we found that the protein expression on our western blot was now similar to
TRPP2-F604P with 3-fold less RNA concentration (1.8 µg/µl) (Fig 3B). On western blot,
we usually can see several higher molecular weight oligomers of TRPP2, in addition to
the monomer band at approximately 120 kDa. Occasionally, we see a different pattern of
these bands between TRPP2-F604P and TRPP2-F604P-12aa (Fig 3C). We see the same
!
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amount of monomer, but much more oligomers for the 12aa mutant. It seems the extra 12
aa may leads to some folding issues after protein synthesis that cause the oligomers more
resistance to SDS treatment.

Figure 3. The 12 aa mutation reduces TRPP2 channel expression in Xenopus
oocytes. Immunoblotting showing the expression of TRPP2-F604P and TRPP2-F604P12aa in Xenopus oocytes. (A) TRPP2-F604P (1.8µg/µl) and TRPPP2-F604P_12aa
(1.8µg/µl). (B) TRPP2-F604P (1.8µg/µl), TRPP2-F604P-12aa (1.8µg/µl), TRPP2F604P-12aa (5.4µg/µl). (C) TRPP2-F604P (1.8µg/µl) and TRPP2-F604P-12aa
(5.4µg/µl). “Star” represents the monomer band size corresponding to the expressed
protein at approximately 120kDa. “Arrows” show the oligomers.

!
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Next, using the two-electrode voltage clamp (TEVC) system, we recorded ion channel
activity of TRPP2-F604P and TRPP2-F604P-12aa. Three different extracellular solutions
have been used in our recording. Since TRPP2 is a cation-permeable nonselective cation
channel, we first use 100mM Na+ solution to test the cation current. TRPP2 has been
known to be blocked by extracellular Ca2+ (Arif Pavel et al., 2016). Thus, we also tested
the solution with 100 mM Na+ and 2 mM Ca2+. Lastly, TRPP2-F604P has very low or no
Ca2+ permeability (Arif Pavel et al., 2016; Wang et al, 2019). To test whether 12 aa
mutant leads to any change on this property, we use the third solution in which all
monovalent ions have been replaced by 70mM Ca2+. Our results show that the 12 aa
mutation leads to no change on Ca2+ blocking and the Ca2+ permeability. In low (2mM)
and high (70mM) extracellular Ca2+ solution, there is blockage of inward current (Fig 4A
and 4C, respectively), and in Ca2+-free solution (100mM Na+), there is no inhibition (Fig
4B). However, 12 aa mutant greatly affected the channel activity. TRPP2-F604P at
1.8µg/µl gives much bigger current compared to TRPP2-F604P-12aa at 1.8µg/µl and
5.4µg/µl. When TRPP2-F604P and TRPP2-F604P-12aa RNA concentration is kept the
same, the latter gives a much lower current and expression, and when TRPP2-F604P12aa RNA concentration is increased, it still gives a lower activity than TRPP2-F604P.
This confirms that the 12aa mutation reduces TRPP2 ion channel activity.
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Figure 4. The 12 aa mutation reduces TRPP2 ion channel activity. Average I-V
relationship (left) and normalized bar graph (right) showing the current sizes in
solutions containing 2mM Ca2+ + 100mM Na+ (A) , 100mM Na+ (B), and 70mM
Ca2+ (C). n = number of oocytes tested. TRPP2-F604P (1.8µg/µl) (blue), TRPP2F604P_12aa (5.4µg/µl) (green),TRPP2-F604P_12aa (1.8µg/µl) (red). Un-injected
oocytes (purple) as negative control. Bar graphs show the currents at +80mV. Error
bars represent standard error. *** significant by t-test; n.s.= no significance.!
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The reduction of the TRPP2 current in the 12 aa mutant can be caused either by reduced
channel function or by reduced plasma membrane expression. To distinguish the potential
effects, we compared the plasma membrane expression of our samples in Xenopus
oocytes by purifying the biotinylated surface proteins. Surface biotinylation was
performed to monitor protein trafficking and in our result, the WT expressed better on
surface than the 12 aa mutant. These results indicate that the 12 aa mutant also reduces
channel trafficking besides its effect on protein folding.

Figure 5. The 12 aa mutant reduces TRPP2 surface expression. TRPP2-F604P (1.8µg/µl),
TRPP2-F604P-12aa (1.8µg/µl), and TRPP2-F604P-12aa (5.48µg/µl) are used in oocyte
injection. Whole cell lysate (left three lanes) and surface expression (right three lanes) are
shown. Arrows correspond to the oligomers on the TRPP2-F604P-12aa.

3.2 The extra 12 aa on TRPP2 reduces the activity of PC1-CTF/TRPP2-AA complex
channel
Our laboratory has previously generated another TRPP2 GOF mutation, L677A_N681A
(TRPP2_AA) (Wang et al., 2019). L677 and N681 form the lower gate constriction pore
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of TRPP2 (Shen et al, 2016). By mutating both amino acids into alanine, this channel
reduces the bulkiness of the side chain in the pore, and gives constitutive ion conductance
of TRPP2 (Wang et al, 2019). It produced significant currents in a bath solution
containing 2mM Ca2+ and 100mM Na+ when expressed in oocytes (Wang et al, 2019).
This mutant channel gives current size roughly double that of TRPP2-F604P. More
importantly, this mutation shows GOF effect in the complex channel formed by PC1 and
TRPP2 (Wang et al, 2019), making it a very useful GOF mutant for studying the function
of the PC1/TRPP2 complex channel.
Cleavage at the GPS site dissects PC1 into an NTF (PC1-NTF) and CTF (PC1-CTF)
(Fig. 1) (Kurbegovic, et al 2014). CTF (sometimes we also call it TM11) has 11
transmembrane domains and an intracellular C-terminal tail. We have found that PC1CTF is sufficient to form a functional channel with PC2 (Wang et al, 2019). We next
tested whether the 12aa mutation affects the heteromeric PC1/PC2 channel function by
co-expressing TRPP2-L677A-N681A_12aa (P2-AA-12aa) with PC1-CTF (TM11).
Different from that of the TRPP2-F604P, the extracellular 2mM Ca2+ did not block the
inward current of TRPP2-AA/TM11 (Fig. 6A). In 100mM Na+, there are larger inward
and outward current for TRPP2-AA/TM11 (Fig 6B). Importantly, the TRPP2-AA/TM11
channel is permeable to Ca2+. By replacing the extracellular monovalent cations with
70mM Ca2+, TRPP2-AA/TM11 results in robust current (Fig. 6C). This current is a
mixture of TRPP2-AA/TM11 current and the Ca2+ induced chloride channel current
(Wang et al., 2019). When comparing the P2-AA/TM11 with P2-AA-12aa/TM11, we
observe a great reduction in current size of the complex with the 12aa pathogenic
mutation, indicating that the 12 aa mutant may also affect the channel function of the
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PC1/TRPP2 complex. In the future, we would need to check the surface expression and
the protein expression via western blot to better understand its mechanism.

Figure 6. The 12 aa mutant reduces the channel function of PC1-CTF/TRPP2-AA.
Representative I–V curve (left) and bar graph at +80mV (right) showing current sizes in bath
solutions containing 2mM Ca2+/100mM Na+(A), 100mM Na+ (B) and 70mM Ca2+ (C)
respectively.

3.3 Discussion and Future Direction
Our laboratory has generated GOF TRPP2 mutants to facilitate its study further.
It provides a tool to study the pathogenic mutations of ADPKD. In our results, the 12aa
mutation led to a significant reduction on channel activity of TRPP2-F604P. Immunoblot
analysis shows the 12 aa mutant reduces the expression of TRPP2. Also, we observe
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more oligomers in TRPP2-F604P-12aa compared to the wild-type. The additional twelve
amino acids on the C-terminus of the TRPP2 protein seems to exert a pathogenic effect
reducing the TRPP2 ion channel activity and may also affect the folding and/or assembly
of the protein. The additional twelve amino acids that have reduced the expression may
be caused by the conformational change due to the higher molecular weight bands. This
changed conformation leads to more degradation. Due to the high oligomers, it would be
necessary to run a Blue Native-PAGE to analyze how the 12aa mutant affects protein
assembly.
Additionally, we have shown that the 12 aa mutant reduces the surface expression of
TRPP2, an effect may be related to its effect on protein folding/assembly. This
information will provide more insight of these pathogenic mutations affecting the
proteins underlying ADPKD.

Studying the PC1/TRPP2 channel would gain more insight into the proteins involved in
the complex, since the complex is essential for renal tubular differentiation. The function
of this complex is unknown due to the lack of a functional assay. Therefore, GOF mutants
were created to dissect its role. However, the GOF F604P was unable to open the
PC1/PC2 channel, hence, the intent to create a new GOF, TRPP2-L677A-N681A. Coexpressing the 12aa mutation with PC1-CTF/TRPP2-AA, allowed us to understand the
affect of this mutation on this channel, and it exhibited a lower current size. However, a
further investigation and surface and western expression is required to make a solidified
conclusion of how the 12aa mutation affects the PC1/TRPP2 complex channel.
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CHAPTER 4
THE EFFECT OF STUM PROTEIN ON PC1/TRPP2 CHANNEL FUNCTION

4.1 The effect of co-expressing C1orf95 on the activity of the PC1-CTF/TRPP2-AA
complex channel
The STUM gene, short for stumble, is a mechanosensory transduction mediator homolog,
first identified in Drosophila, due to a walking impairment. Diseases associated with
STUM include, Shwartz-Jampel Sydrome, Type 1 and Charcot-Marie-Tooth Disease,
Axonal, Type 2N. The human ortholog of the STUM gene is a part of the SPEC3 family,
C1orf95 (Chromosome 1 Open Reading Frame 95). Two isoforms of C1orf95 exist
within the human kidney with difference in exon 3 inclusion. Here we named them
C1orf95+E3 (exon 3 present) and C1orf95-E3 (no exon 3 skipped). It has been reasoned
that this protein co-localizes with PKD1 and ESCRT (data not shown). Our collaborator,
Dr. Christopher Ward, at University of Kansas Medical Center found that both C1orf95
present in exosomes in human urine and can be co-IPed with PC1 (personal
communication). In order to study the role of C1rof95 in regulating PC1/TRPP2 complex
channel, we co-expressed V5-tagged C1orf95+E3 and C1orf95-E3 with the PC1/TRPP2
complex in oocytes and measured the functional change of the channel. In order to record
the channel current, we have used a short PC1 C-terminal fragment (named TM11) and
TRPP2-L677A-N681A (P2-AA) GOF mutant generated in our laboratory (Wang et al,
2019).
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All three co-expressed proteins were measured as the same total RNA concentration,
1µg/µl. P2-AA /TM11 (1µg/µl), P2-AA/TM11/C1orf95-E3 (1µg/µl), and P2AA/TM11/C1orf95-E3 (1µg/µl). Our expression resulted in the STUM protein at
approximately 20 kDa and all three groups exhibited similar expression (Fig 7A and 7B).
However, all three groups exhibit a similar current pattern and size in multiple bath
solutions, including low Ca2+ (100 mM Na+, 2mM Ca2+) and high Ca2+ (70mM Ca2+), and
in Ca2+-free (100mM Na+) extracellular solutions (Fig. 8 A-C). The representative current
shows no significant difference between the co-expressed groups.

Figure 7. Co-expression of STUM with PC1-CTF/TRPP2-AA (A) Immunoblot analysis of
co-expressed proteins with PKD2 and V5 antibody. P2 bands expressed between 100-130kDa
and STUM bands expressed at 20kDa. (B) Immunoblot analysis of co-expressed proteins
with PKD1 antibody. P1 bands expressed at 110kDa.
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Figure 8. Co-expression of C1orf95 proteins does not affect the PC1-CTF/TRPP2-AA
ion channel activity. Average I-V curves (left) and bar graphs (right) show the currents of
P2-AA/TM11, n=8 (blue), P2-AA/TM11/C1orf95-E3, n=14 (red), P2AA/TM11/C1orf95+E3, n=8 (green), and un-injected oocytes (purple) in 2mM Ca2+ +
100mM Na+ (A), 100mM Na+ (B), and 70mM Ca2+ (C) extracellular solutions.
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4.2 Discussion and Future Direction
Our immunoblot analysis shows similar expression for P2-AA/TM11, P2AA/TM11/C1orf95+E3 and P2-AA/TM11/C1orf95-E3 samples (Fig. 7). Although, our
collaborator found an interaction with C1orf95 with the PC1/TRPP2 complex of kidney
exosomes, we were not able to find an effect of co-expressing C1orf95 on channel
activity. However, we cannot rule out the possibilities that C1orf 95 may be involved in
signaling pathways induced by PC1/TRPP2 complex and play a role in ADPKD.
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